Evidence map›Paper›PMID 33022639›Full record

GuidelineJournal of the National Comprehensive Cancer Network : JNCCN2020

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020.

Dawn Provenzale, Reid M Ness, Xavier Llor, Jennifer M Weiss, Benjamin Abbadessa, Gregory Cooper, Dayna S Early, Mark Friedman, Francis M Giardiello, Kathryn Glaser and 19 more

Registry-linked trialOpen access · bronzeAbstract readPractice Guideline
In one paragraph

Guideline in Journal of the National Comprehensive Cancer Network : JNCCN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05234177 (Tempus CRC Surveillance Study), which is not on this map. Cited by 82 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05234177 recruitingnot on this mapstarted 2022, after this paper: background citation

Tempus CRC Surveillance Study: A Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients With Colorectal Cancer (CRC) Using Comprehensive Next-Generation Sequencing (NGS)Assays

TypeobservationalSponsorTempus AIRan2022 to 2029Enrolled300ConditionsColorectal CancerArmsObservation
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 2 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-Analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Pooled it
  3. Trial
  4. Impact of MMR status on preoperative CT-based lymph node overstaging in right-sided colon cancer: a retrospective analysis.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Methylation ofAdvanced biomedical research · 2025
    Article
  19. Review
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 2 countries.

Dawn ProvenzaleDuke Cancer Institute.
Reid M NessVanderbilt-Ingram Cancer Center.
Xavier LlorYale Cancer Center/Smilow Cancer Hospital.
Jennifer M WeissUniversity of Wisconsin Carbone Cancer Center.
Benjamin AbbadessaUC San Diego Moores Cancer Center.
Gregory CooperCase Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Dayna S EarlySiteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Mark FriedmanMoffitt Cancer Center.
Francis M GiardielloThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Kathryn GlaserRoswell Park Comprehensive Cancer Center.
Suryakanth GuruduMayo Clinic Cancer Center.
Amy L HalversonRobert H. Lurie Comprehensive Cancer Center of Northwestern University.
Rachel IssakaFred Hutchinson Cancer Center/Seattle Cancer Care Alliance.
Rishi JainFox Chase Cancer Center.
Priyanka KanthHuntsman Cancer Institute at the University of Utah.
Trilokesh KidambiCity of Hope National Medical Center.
Audrey J LazenbyFred & Pamela Buffett Cancer Center.
Lillias MaguireUniversity of Michigan Rogel Cancer Center.
Arnold J MarkowitzMemorial Sloan Kettering Cancer Center.
Folasade P MayUCLA Jonsson Comprehensive Cancer Center.
Robert J MayerDana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center.
Shivan MehtaAbramson Cancer Center at the University of Pennsylvania.
Swati PatelUniversity of Colorado Cancer Center.
Shajan PeterO'Neal Comprehensive Cancer Center at UAB.
Peter P StanichThe Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
Jonathan TerdimanUCSF Helen Diller Family Comprehensive Cancer Center; and.
Jennifer KellerNational Comprehensive Cancer Network.
Mary A DwyerNational Comprehensive Cancer Network.
Ndiya OgbaNational Comprehensive Cancer Network.
National Comprehensive Cancer NetworkUniversity of Colorado Cancer Center · USBarnes-Jewish Hospital · USCancer Institute (WIA) · INCity Of Hope National Medical Center · USCleveland Clinic · USDana-Farber Brigham Cancer Center · USFox Chase Cancer Center · USFred and Pamela Buffett Cancer CenterMemorial Sloan Kettering Cancer Center · USMoffitt Cancer Center · USPancreatic Cancer Action Network · USRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversitySeattle Cancer Care Alliance · USSidney Kimmel Comprehensive Cancer Center · USSmilow Cancer Hospital · USThe Ohio State University · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of California, San Diego · USUniversity of Colorado Denver · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approachK08CA241296 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ISSAKA, RACHEL B. · 2019 to 2023
$1.1M
NCATS NIH HHS UL1 TR001863NCI NIH HHS K08 CA241296NIMHD NIH HHS L32 MD012892
6 · The paper itself

Abstract

The NCCN Guidelines for Colorectal Cancer (CRC) Screening describe various colorectal screening modalities as well as recommended screening schedules for patients at average or increased risk of developing sporadic CRC. They are intended to aid physicians with clinical decision-making regarding CRC screening for patients without defined genetic syndromes. These NCCN Guidelines Insights focus on select recent updates to the NCCN Guidelines, including a section on primary and secondary CRC prevention, and provide context for the panel's recommendations regarding the age to initiate screening in average risk individuals and follow-up for low-risk adenomas.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerHumansMass Screening

Identifiers

PMID33022639
PMCPMC8311627
OpenAlexW3091900404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.